Proton Cranio-spinal Irradiation for Leptomeningeal Metastasis

Recruiting N/A Interventional Study
Leptomeningeal Metastasis
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
50 (estimated)
Sponsor
University of Aarhus · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Leptomeningeal metastasis is a rare but serious complication to cancer, with a grave prognosis. No efficient treatment exists. Recent data suggest that craniospinal radiotherapy lead to superior survival and CNS control compared to focal photon radiotherapy. We want to offer Danish patients the new treatment, but within a protocol, as this is new data with an new treatment principle

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Metastasis to the leptomeningeal space (LM) surrounding the brain and/ or spinal cord * Metastasis verified by MRI or CSF cytology * Karnofsky \>=60 (requiring some help, can take care of most personal requirements) * Adequate bone marrow function * Haemoglobin \> 5 mmol/l …
Contacts

Kenneth Jensen, PhD

+45 78 45 64 00

kennjens@rm.dk

CONTACT

Dorte Winther, M.H.Sc.

+45 78 45 64 00

dorte.skriver.winther@auh.rm.dk

CONTACT